by Alex Aleshin, and Peter L. Greenberg

Slides:

Advertisements

Similar presentations

RNA interference in biology and disease by Carol A. Sledz, and Bryan R. G. Williams Blood Volume 106(3): August 1, 2005 ©2005 by American Society.

Advertisements

Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms by Pontus Lundberg, Axel Karow, Ronny Nienhold, Renate Looser,

Myelodysplastic Syndromes

Volume 20, Issue 2, (February 2012)

Production and clinical development of nanoparticles for gene delivery

209. Use of Helicobacter pyroli Neutrophil Activating Protein (NAP) as an Immune- Modulatory Agent To Enhance the Efficacy of Oncolytic Adenovirus Therapy.

Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene by A.

by Nadine Martel, James Lee, and Philip S. Wells

Positioning NK-κB in multiple myeloma

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

by Sandra Luna-Fineman, Kevin M. Shannon, Susan K

Genome-editing Technologies for Gene and Cell Therapy

Validation of the Nordic Scoring System for Erythropoietic Stimulating Agents in MDS Using IWG 2006 Erythroid Response Criteria by Jennifer Jayakar, Richard.

Myelodysplastic Syndromes

by Corey S. Cutler, John Koreth, and Jerome Ritz

Genetic sequence analysis of inherited bleeding diseases

627. Non-Invasive, Multimodal Imaging of Microvesicles with Metabolically Biotinylated, Membrane-Bound Gaussia Luciferase Molecular Therapy Volume.

Taking a leaf from the book of oral tolerance

162. Stability of Polymer/Plasmid DNA Complexes In Vitro and In Vivo

281. Rapid Generation of Induced Pluripotent Stem Cells (iPSCs) from the Urine of a Patient with Duchenne Muscular Dystrophy Molecular Therapy Volume.

Direct Conversion of Skin Cells into Blood: Alchemy or Science?

Molecular Therapy Volume 20, Pages S261-S262 (May 2012) DOI: /S (16)

Volume 25, Issue 10, Pages (October 2017)

Evolving Gene Therapy in Primary Immunodeficiency

Activity of eltrombopag in severe aplastic anemia

Immunotherapy for acute lymphoblastic leukemia: from famine to feast

Escaping the Valley of Death

733. Somatically Repairing Compound Heterozygous Recessive Mutations by Chromosomal Cut-and-Paste for In Vivo Gene Therapy Dan Wang, Haiwei Mou, Karen.

Multicenter Biologic Assignment Trial Comparing Reduced-Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive.

724. Blood-Derived Endothelial Progenitor Cells Can Be Isolated With a Novel Method of Diluted Whole Blood Incubation with AMD3100-Induced Mobilization.

Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial by Jessica C. Cardenas, Xu Zhang, Erin.

Genetic heterogeneity of cytogenetically normal AML with mutations of CEBPA by Nikola P. Konstandin, Friederike Pastore, Tobias Herold, Annika Dufour,

Genome-editing Technologies for Gene and Cell Therapy

Molecular Therapy Volume 20, (May 2012) DOI: /S (16)

Molecular Therapy Volume 7, Issue 5, (May 2003) DOI: /S (16)

A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes by Chi-Yuan Yao, Ching-Hsuan Chen, Huai-Hsuan Huang, Hsin-An Hou, Chien-Chin.

847. Eradication of Therapy-Resistant Human Prostate Tumors Using an Ultrasound Guided Site-Specific Cancer Terminator Virus Delivery Approach Molecular.

133. Survival with Normal Neurological Development of the Juvenile Lethal Urea Cycle Defect Arginase Deficient Mouse with AAV Gene Therapy Molecular.

by Kaiwen Chen, Matthew P. Cheng, Sarah P

Volume 26, Issue 2, Pages (February 2018)

68. Site Specific Intra-Placental Gene Transfer Corrects Fetal Growth Restriction in a Novel Mouse Model of Placental Insufficiency (PI) Molecular.

521. Multiplex Genome Editing of TCR°/CD52 Genes as a Platform for “Off the Shelf” Adoptive T-Cell Immunotherapies Molecular Therapy Volume 22, Pages.

by Fumiko Chino, Arif H. Kamal, Junzo Chino, and Thomas W. LeBlanc

Prevalence of inherited blood disorders and associations with malaria and anemia in Malawian children by Patrick T. McGann, Anne M. Williams, Graham Ellis,

Molecular Therapy Volume 18, Pages S260-S261 (May 2010) DOI: /S (16)

Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas by Alexandra Nagy, Aparna.

521. AAV Immunotherapy Induces Functional Antigen Specific Regulatory T-Cells to a Neuroantigen: A Potential Treatment for MS Brad E. Hoffman Molecular.

by Christine L. Kempton, and Amanda B. Payne

by Terra L. Lasho, Mythri Mudireddy, Christy M. Finke, Curtis A

by Michael R. DeBaun, and Ellen Wright Clayton

by Elizabeth C. Neil, and Lisa M. DeAngelis

The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes by Caroline J. McNamara, Tony Panzarella,

773. Detection of RNA Interference (RNAi) Mediated mRNA Cleavage in Fresh Injected Tumor Tissue from Patients in a Phase I Trial of pbi-shRNA™ Lipoplex.

740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells Molecular Therapy Volume 20, Pages S285-S286.

by H. Ddungu, M. Waiswa, R. Kruisselbrink, P. Kagoma, and M. Crowther

MRD detection in multiple myeloma: comparison between MSKCC 10-color single-tube and EuroFlow 8-color 2-tube methods by Mikhail Roshal, Juan A. Flores-Montero,

Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin by Sarah L. Reeves, Hannah K. Jary, Jennifer.

Molecular Therapy Volume 21, Pages S247-S248 (May 2013)

A case of lenalidomide-dependent myelodysplastic syndrome

One step forward, 2 steps back: The enigma of preschool wheeze

86. A Highly Compact Epitope-Based Marker Suicide Gene for Safer and Easier Adoptive T-Cell Gene Therapy Molecular Therapy Volume 20, Pages S35-S36.

Treatment versus Transplant for Challenging Hematologic Disorders

Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.

Volume 2(Supplement 1):39-41

Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015 by Evaren E. Page, Johanna A.

Albert Y. Wu, MD, Sanjiv Sur, MD, J. Andrew Grant, MD

by Catherine Lai, Vishal Ranpura, Colin Wu, Matthew J. Olnes, Ankur R

Initial treatment of CLL: integrating biology and functional status

Algorithm for treatment choice in MDS patients after failure of HMA therapy. Algorithm for treatment choice in MDS patients after failure of HMA therapy.

624. Randomized Phase II Trial of Adjuvant Autologous Tumor Cell Vaccine (FANG™) for High Risk Stage III/IV Ovarian Cancer: Preliminary Results Molecular.

Presentation transcript:

by Alex Aleshin, and Peter L. Greenberg Molecular pathophysiology of the myelodysplastic syndromes: insights for targeted therapy by Alex Aleshin, and Peter L. Greenberg BloodAdv Volume 2(20):2787-2797 October 23, 2018 © 2018 by The American Society of Hematology

Alex Aleshin, and Peter L. Greenberg Blood Adv 2018;2:2787-2797 © 2018 by The American Society of Hematology

Molecular targets and therapeutics in MDS Molecular targets and therapeutics in MDS. The heterogeneity of molecular abnormalities extant within the MDS spectrum of disorders, involving a variety of somatically mutated genes and biologic functions, is demonstrated along with therapeutic agents in clinical trials focused on targeting these lesions. Molecular targets and therapeutics in MDS. The heterogeneity of molecular abnormalities extant within the MDS spectrum of disorders, involving a variety of somatically mutated genes and biologic functions, is demonstrated along with therapeutic agents in clinical trials focused on targeting these lesions. Alex Aleshin, and Peter L. Greenberg Blood Adv 2018;2:2787-2797 © 2018 by The American Society of Hematology